Back to Search
Start Over
[PARP inhibitors in first-line of ovarian cancers].
- Source :
-
Bulletin du cancer [Bull Cancer] 2020 Jan; Vol. 107 (1), pp. 4-5. Date of Electronic Publication: 2020 Jan 10. - Publication Year :
- 2020
- Subjects :
- Benzimidazoles economics
Benzimidazoles therapeutic use
Clinical Trials as Topic
Female
Genes, BRCA1
Genes, BRCA2
Humans
Indazoles economics
Indazoles therapeutic use
Maintenance Chemotherapy
Ovarian Neoplasms genetics
Ovarian Neoplasms pathology
Phenotype
Phthalazines economics
Phthalazines therapeutic use
Piperazines economics
Piperazines therapeutic use
Piperidines economics
Piperidines therapeutic use
Poly(ADP-ribose) Polymerase Inhibitors economics
Ovarian Neoplasms drug therapy
Poly(ADP-ribose) Polymerase Inhibitors therapeutic use
Subjects
Details
- Language :
- French
- ISSN :
- 1769-6917
- Volume :
- 107
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Bulletin du cancer
- Publication Type :
- Periodical
- Accession number :
- 31928735
- Full Text :
- https://doi.org/10.1016/j.bulcan.2019.10.009